The Antibody Company - SouthernBiotech

Rat IgG-APC/CY5.5

Cat. No.
0.1 mg  
Price (USD)

Add to Cart
Source Normal rat serum
Format/Conjugate APC/CY5.5 (Allophycocyanin/Cyanine 5.5)
Buffer Formulation Supplied in PBS/NaN3 and a stabilizing agent
Concentration 0.1 mg/mL
Volume 1.0 mL
Storage & Handling Store at 2-8°C
Please refer to product specific (M)SDS
Quality tested applications for relevant formats include -
Flow Cytometry 3-9
Other referenced applications for relevant formats include -
Immunohistochemistry-Paraffin Sections 10
Immunocytochemistry 11
Blocking 12
In vivo Control 13-15
Recommended Dilutions Please refer to product specific Technical Bulletin
1. Doymaz MZ, Rouse BT. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci. 1992;33:2165-73. (ELISA)
2. Swanson CL, Wilson TJ, Strauch P, Colonna M, Pelanda R, Torres RM. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med. 2010;207:1485-1500. (ELISA)
3. Garbe A, Buck J, Hämmerling U. Retinoids are important cofactors in T cell activation. J Exp Med. 1992;176:109-17. (FC)
4. Mierke CT, Ballmaier M, Werner U, Manns MP, Welte K, Bischoff SC. Human endothelial cells regulate survival and proliferation of human mast cells. J Exp Med. 2000;192:801-11. (FC)
5. Abernethy NJ, Hagan C, Tan PL, Watson JD. Dysregulated expression of CD69 and IL-2 receptor α and β chains on CD8+ T lymphocytes in flaky skin mice. Immunol Cell Biol. 2000;78:596-602. (FC)
6. Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V, et al. Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes. J Exp Med. 2002;196:379-87. (FC)
7. Cosmi L, Liotta F, Lazzeri E, Francalanci M, Angeli R, Mazzinghi B, et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood. 2003;102:4107-14. (FC)
8. Welner R, Swett DJ, Pelsue SC. Age-related loss of bone marrow pre-B- and immature B-lymphocytes in the autoimmune-prone flaky skin mutant mice. Autoimmunity. 2005;38:399-408. (FC)
9. Abbasi S, Shin D, Beaty N, Masiuk M, Chen S, Gonzalez-Garcia I, et al. Characterization of monoclonal antibodies to the plasma cell alloantigen ENPP1. Hybridoma. 2011;30:11-17. (FC)
10. Almholt K, Lund LR, Rygaard J, Nielsen BS, Danø K, Rømer J, et al. Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice. Int J Cancer. 2005;113:525-32. (IHC-PS)
11. Lu DP, Tian L, O'Neill C, King NJ. Regulation of cellular adhesion molecule expression in murine oocytes, peri-implantation and post-implantation embryos. Cell Res. 2002;12:373-83. (ICC)
12. Pepin AC, Tandon R, Cattori V, Niederer E, Riond B, Willi B, et al. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats. Virus Res. 2007;127:9-16. (Block)
13. Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood. 1996;88:75-81. (In vivo control)
14. Cheng M, Nguyen M, Fantuzzi G, Koh TJ. Endogenous interferon-γ is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol. 2008;294:C1183-91. (In vivo control)
15. Ma Y, Zhang X, Bao H, Mi S, Cai W, Yan H, et al. Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PloS One. 2012;7(7):e40763. (In vivo control)
Cy® is a registered trademark of GE Healthcare
Back to Product List
Customer & Technical Service 800.722.2255 (USA & Canada) . 205.945.1774 . Fax 205.945.8768
Copyright © 2017 SouthernBiotech
Follow SouthernBiotech